Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Brain Ischemia drug therapy"" wg kryterium: Temat


Tytuł :
Strong Recommendations Are Inappropriate in Person-Centred Care:The Case of Anti-Platelet Therapy
Autorzy :
Dowie, Jack
Kaltoft, Mette Kjer
Pokaż więcej
Temat :
Anti-platelet therapy
GRADE
MAGIC
Multi-Criteria Decision Analysis
Person-centred decision support
Preferences
Transient ischaemic attack
Brain Ischemia/drug therapy
Platelet Aggregation Inhibitors/therapeutic use
Humans
Patient-Centered Care
Stroke/drug therapy
Ischemic Attack, Transient/drug therapy
Clopidogrel
Źródło :
Dowie, J & Kaltoft, M K 2019, Strong Recommendations Are Inappropriate in Person-Centred Care : The Case of Anti-Platelet Therapy . in J Mantas, A Hasman, P Gallos, A Kolokathi, M S Househ & J Liaskos (eds), Health Informatics Vision : From Data via Information to Knowledge . IOS Press, Studies in Health Technology and Informatics, vol. 262, pp. 110-113 . https://doi.org/10.3233/SHTI190029
Tytuł :
From single drug targets to synergistic network pharmacology in ischemic stroke
Autorzy :
Larsen, Simon J.
Guney, Emre
Schmidt, Harald H. H. W.
Casas, Ana I.
Hassan, Ahmed A.
Gomez-Rangel, Vanessa
Elbatreek, Mahmoud
Kleikers, Pamela W. M.
Egea, Javier
López, Manuela G.
Baumbach, Jan
Pokaż więcej
Temat :
Reactive Oxygen Species/metabolism
NITRIC-OXIDE
Blood-Brain Barrier/metabolism
HYDROGEN-PEROXIDE
Mice
NOX4
Pyrazoles/pharmacology
Nitric Oxide Synthase Type II/genetics
NADPH Oxidase 4/drug effects
Drug Discovery
SIMILARITY
NG-Nitroarginine Methyl Ester/pharmacology
Pharmacology
Nitric Oxide Synthase Type I/genetics
Animals
Female
Nitric Oxide Synthase/drug effects
OXYGEN
Nitric Oxide Synthase Type III/genetics
Brain Ischemia/drug therapy
Pyridones/pharmacology
EXPRESSION
BIOLOGY
OFF-TARGET
PNAS Plus
Cell Death/drug effects
BRAIN
Stroke
Biological Sciences
Drug Combinations
Disease Models, Animal
CELLS
Network pharmacology
Stroke/drug therapy
PREDICTION
Drug Synergism
Network analysis
Male
Źródło :
Proceedings of the National Academy of Sciences of the United States of America, 116(14), 7129 - 7136. National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America
Casas, A I, Hassan, A A, Larsen, S J, Gomez-Rangel, V, Elbatreek, M, Kleikers, P W M, Guney, E, Egea, J, López, M G, Baumbach, J & Schmidt, H H H W 2019, ' From single drug targets to synergistic network pharmacology in ischemic stroke ', Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 14, pp. 7129-7136 . https://doi.org/10.1073/pnas.1820799116
Opis pliku :
application/pdf
Tytuł :
Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke:A Systematic Review based on Pre-Clinical Studies
Autorzy :
Marlet, Ida R
Ölmestig, Joakim N E
Vilsbøll, Tina
Rungby, Jørgen
Kruuse, Christina
Pokaż więcej
Temat :
Brain Ischemia/drug therapy
Neuroprotective Agents/pharmacology
endocrine system
Stroke/drug therapy
Animals
Humans
digestive, oral, and skin physiology
Glucagon-Like Peptide 1/agonists
hormones, hormone substitutes, and hormone antagonists
Źródło :
Marlet, I R, Ölmestig, J N E, Vilsbøll, T, Rungby, J & Kruuse, C 2018, ' Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke : A Systematic Review based on Pre-Clinical Studies ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 6, pp. 559-569 . https://doi.org/10.1111/bcpt.12974
Tytuł :
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
Autorzy :
Duley, Lelia
Sprigg, Nikola
Bath, Philip M.W.
Appleton, Jason P.
Beridze, M.
Christensen, Hanne
Dineen, Robert A.
England, Timothy J.
Heptinstall, Stan
James, Marilyn
Krishnan, Kailash
Markus, H.S.
Pocock, Stuart J.
Ranta, A.
Robinson, Thompson G.
Flaherty, Katie
Scutt, Polly
Venables, G.
Woodhouse, Lisa J.
TARDIS Investigators
Pokaż więcej
Temat :
Aspirin/adverse effects
Brain Ischemia/drug therapy
Aged
cardiovascular diseases
Treatment Outcome
Research Support, Non-U.S. Gov't
Randomized Controlled Trial
Acute ischaemic stroke, Acute transient ischaemic attack (TIA), Aspirin, Bleeding, Clopidogrel, Dipyridamole, Randomised controlled trial
Platelet Aggregation Inhibitors/adverse effects
Dipyridamole/adverse effects
Severity of Illness Index
Stroke/drug therapy
Journal Article
Multicenter Study
Drug Therapy, Combination
Female
Humans
Ticlopidine/adverse effects
Male
Źródło :
Bath, P M, Appleton, J P, Beridze, M, Christensen, H, Dineen, R A, Duley, L, England, T J, Heptinstall, S, James, M, Krishnan, K, Markus, H S, Pocock, S, Ranta, A, Robinson, T G, Flaherty, K, Scutt, P, Venables, G S, Woodhouse, L J & Sprigg, N 2017, ' Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial ', International Journal of Stroke, vol. 12, no. 5, pp. 524-538 . https://doi.org/10.1177/1747493016677988
Opis pliku :
application/pdf; PDF

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies